<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CEBD0459-3618-46C0-981C-734AAAABCE4B"><gtr:id>CEBD0459-3618-46C0-981C-734AAAABCE4B</gtr:id><gtr:name>MRC Mammalian Genetics Unit</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:line4>Didcot</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CEBD0459-3618-46C0-981C-734AAAABCE4B"><gtr:id>CEBD0459-3618-46C0-981C-734AAAABCE4B</gtr:id><gtr:name>MRC Mammalian Genetics Unit</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:line4>Didcot</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C226AA7E-7DA8-4490-BA17-65E6F6E8D22A"><gtr:id>C226AA7E-7DA8-4490-BA17-65E6F6E8D22A</gtr:id><gtr:firstName>Ruth</gtr:firstName><gtr:surname>Arkell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U142670369"><gtr:id>FCE1E2C6-52E2-432A-8FBE-5B59FAEA8C1F</gtr:id><gtr:title>Early development</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U142670369</gtr:grantReference><gtr:abstractText>The research aims to understand the causes of death before birth and of birth defects. This is a very difficult area to study for two reasons. Firstly, because the human embryo develops in the womb it is difficult to actively study these processes in humans. Secondly, embryonic development is very complex and many instances of aberrant development may be caused by more than one gene. However, it is clear that it is crucial that we begin to understand the processes by which genes control embryonic development. There are now over 3000 documented types of birth defects, meaning that a significant proportion of the population is directly affected by the consequences of incorrect embryonic development. Additionally, it is now known that the genes that are used during embryonic development are instrumental in the establishment and growth of cancers. More recently, the prospect of using stem cells for the treatment of a variety of human diseases has focused further attention on this area of research. Because of the impossibility of using humans for this type of research, this programme aims to generate animal models of congenital defects and to use these to identify and study the genes that contribute to the defects.</gtr:abstractText><gtr:technicalSummary>Research within this programme is focused on the identification and characterisation of genes that are required for mammalian embryonic development. Adult form and function is dependent upon the events of embryogenesis and it is crucial for human health that we gain a better understanding of the genetic control of development. There are now over 3000 documented non-chromosomal, multiple congenital anomaly syndromes. Moreover, in recent years it has been recognised that the study of embryology not only enhances our knowledge of congenital defects but also the understanding of later onset diseases that involve, for example, the inappropriate reactivation of genes that control cell growth and differentiation. One of the key stages in embryogenesis is gastrulation. During this period cell movement and cell-cell communication directs differentiation such that a highly patterned embryo with three recognisable axes (anterior-posterior, dorsal-ventral and left-right) is formed. Gastrulation involves the initiation of genetic pathways that will ultimately influence almost every aspect of the adult organism, meaning that relatively small changes during this stage can have dramatic, pleiotropic downstream consequences. It is therefore likely that understanding the genetic control of gastrulation will impact upon a wide variety of dysmorphologies and diseases.||The in utero development of the mammalian embryo precludes the detailed study of embryogenesis in humans, making the recovery of animal models for congenital defects essential. Within the Early Development Programme we are using a phenotype-driven approach to the generation of such models. We have currently isolated a set of pheno-deviants that are relevant to the study of mammalian gastrulation, and have identified the genes responsible for several of the phenotypes. The mutants model a wide variety of human congenital malformations, including neural tube defects, holoprosencephaly, X-linked heterotaxy and cardiac and renal dysmorphologies. We are currently using these models to investigate the mechanism by which the abnormal gene product leads to aberrant embryonic development.</gtr:technicalSummary><gtr:fund><gtr:end>2006-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1997-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>130602</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B68A5322-4FEA-4488-88A2-0F52F9E17DEC</gtr:id><gtr:title>Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22531b9cd6444b8fbcae32050fb34a54"><gtr:id>22531b9cd6444b8fbcae32050fb34a54</gtr:id><gtr:otherNames>Mackenzie FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>gqLPvpPxA1p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8285666-0162-4D3C-8BF0-F3D121AD4215</gtr:id><gtr:title>Role of the transcription factor sox4 in insulin secretion and impaired glucose tolerance.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06e91ef0422a15dfdbc713123b72b053"><gtr:id>06e91ef0422a15dfdbc713123b72b053</gtr:id><gtr:otherNames>Goldsworthy M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>ZAXjjWABJkR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4198C971-1719-46CB-80D1-4B447C92C446</gtr:id><gtr:title>Zic2-associated holoprosencephaly is caused by a transient defect in the organizer region during gastrulation.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6ccace5743a111e39f49604203575ec"><gtr:id>c6ccace5743a111e39f49604203575ec</gtr:id><gtr:otherNames>Warr N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>oNXerN1geBV</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U142670369</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>